Variant report

Variant	esv3427254
Chromosome Location	chr9:22597780-22693940
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:22642399-22642402	GM12878	blood:	n/a	n/a
2	BRCA1	chr9:22669815-22669872	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr9:22683049-22683464	IMR90	lung:	n/a	chr9:22683166-22683179
4	CEBPB	chr9:22625551-22625900	HepG2	liver:	n/a	chr9:22625725-22625736
5	CEBPB	chr9:22683718-22684087	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr9:22693164-22693367	IMR90	lung:	n/a	n/a
7	CEBPB	chr9:22642450-22642606	A549	lung:	n/a	chr9:22642528-22642539
8	CEBPB	chr9:22683155-22683272	A549	lung:	n/a	chr9:22683166-22683179
9	CEBPB	chr9:22660568-22660768	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr9:22625667-22625834	MCF-7	breast:	n/a	chr9:22625725-22625736
11	CEBPB	chr9:22625577-22625907	H1-hESC	embryonic stem cell:	n/a	chr9:22625725-22625736
12	CEBPB	chr9:22683053-22683457	Hela-S3	cervix:	n/a	chr9:22683166-22683179
13	CEBPB	chr9:22611394-22611636	IMR90	lung:	n/a	chr9:22611512-22611523
14	CEBPB	chr9:22611437-22611617	HepG2	liver:	n/a	chr9:22611512-22611523
15	CEBPB	chr9:22683775-22683981	MCF-7	breast:	n/a	n/a
16	CEBPB	chr9:22625550-22625897	A549	lung:	n/a	chr9:22625725-22625736
17	CEBPB	chr9:22625549-22625906	IMR90	lung:	n/a	chr9:22625725-22625736
18	CEBPB	chr9:22683693-22684086	IMR90	lung:	n/a	n/a
19	CEBPB	chr9:22642451-22642589	HepG2	liver:	n/a	chr9:22642528-22642539
20	CEBPB	chr9:22682459-22682654	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr9:22627879-22628176	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr9:22601268-22601655	MCF-7	breast:	n/a	n/a
23	CTCF	chr9:22681020-22681170	HFF	foreskin:	n/a	n/a
24	CTCF	chr9:22635074-22635076	GM10248	blood:	n/a	n/a
25	CTCF	chr9:22665729-22665765	LNCaP	prostate:	n/a	n/a
26	CTCF	chr9:22608233-22608275	GM13976	blood:	n/a	n/a
27	CTCF	chr9:22625521-22625549	Lung_OC	lung:	n/a	n/a
28	CTCF	chr9:22641103-22641137	Lung_OC	lung:	n/a	n/a
29	CTCF	chr9:22660397-22660440	LNCaP	prostate:	n/a	n/a
30	CUX1	chr9:22657565-22657659	GM12878	blood:	n/a	n/a
31	E2F4	chr9:22683640-22684036	MCF10A-Er-Src	breast:	n/a	n/a
32	E2F4	chr9:22683166-22683411	MCF10A-Er-Src	breast:	n/a	n/a
33	EP300	chr9:22682909-22683401	SK-N-SH	brain:	n/a	chr9:22683216-22683225
34	EP300	chr9:22683038-22683420	SK-N-SH_RA	brain:	n/a	chr9:22683216-22683225
35	EP300	chr9:22683711-22684037	Hela-S3	cervix:	n/a	n/a
36	EP300	chr9:22683087-22683417	Hela-S3	cervix:	n/a	chr9:22683216-22683225
37	EP300	chr9:22682646-22682844	Hela-S3	cervix:	n/a	n/a
38	EP300	chr9:22683751-22684006	SK-N-SH_RA	brain:	n/a	n/a
39	EP300	chr9:22682939-22683386	SK-N-SH_RA	brain:	n/a	chr9:22683216-22683225
40	FOS	chr9:22693178-22693368	MCF10A-Er-Src	breast:	n/a	n/a
41	FOS	chr9:22645958-22646232	MCF10A-Er-Src	breast:	n/a	n/a
42	FOS	chr9:22683031-22684068	MCF10A-Er-Src	breast:	n/a	chr9:22683797-22683805 chr9:22683850-22683858 chr9:22683216-22683226 chr9:22683220-22683232 chr9:22683217-22683226 chr9:22683793-22683804 chr9:22683848-22683860 chr9:22683216-22683226
43	FOS	chr9:22693174-22693371	MCF10A-Er-Src	breast:	n/a	n/a
44	FOS	chr9:22693204-22693378	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr9:22683047-22684114	MCF10A-Er-Src	breast:	n/a	chr9:22683797-22683805 chr9:22683850-22683858 chr9:22683216-22683226 chr9:22683220-22683232 chr9:22683217-22683226 chr9:22683793-22683804 chr9:22683848-22683860 chr9:22683216-22683226
46	FOS	chr9:22683079-22683375	MCF10A-Er-Src	breast:	n/a	chr9:22683216-22683226 chr9:22683220-22683232 chr9:22683217-22683226 chr9:22683216-22683226
47	FOS	chr9:22645904-22646258	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr9:22645983-22646206	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr9:22682603-22682814	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr9:22657771-22657919	MCF10A-Er-Src	breast:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:2109017..2109524-chr9:22685897..22686685,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DMRTA1-2	chr9:22682469-22682712	ENSG00000234840.1
2	lnc-DMRTA1-1	chr9:22682609-22682712	NONHSAT130443
3	lnc-DMRTA1-1	chr9:22674434-22674694	NONHSAT130441
4	lnc-DMRTA1-2	chr9:22682609-22682712	ENSG00000234840.1
5	lnc-DMRTA1-1	chr9:22682469-22683267	NONHSAT130441
6	lnc-CDKN2B-5	chr9:22651795-22652209	NONHSAT130440
7	lnc-DMRTA1-1	chr9:22687546-22688453	NONHSAT130441
8	lnc-DMRTA1-1	chr9:22646108-22646877	NONHSAT130441
9	lnc-DMRTA1-1	chr9:22683873-22684083	NONHSAT130441
10	lnc-DMRTA1-1	chr9:22674481-22674642	NONHSAT130443
11	lnc-DMRTA1-9	chr9:22602500-22603039	NONHSAT130439
12	lnc-DMRTA1-10	chr9:22672609-22672712	l_3742_chr9:22664441-22713435_adipose
13	lnc-DMRTA1-9	chr9:22602231-22602323	NONHSAT130439
14	lnc-DMRTA1-2	chr9:22674442-22674642	ENSG00000234840.1
15	lnc-DMRTA1-10	chr9:22664442-22664642	l_3742_chr9:22664441-22713435_adipose
16	lnc-DMRTA1-2	chr9:22646199-22646295	ENSG00000234840.1
17	lnc-DMRTA1-2	chr9:22687546-22687626	ENSG00000234840.1
18	lnc-CDKN2B-5	chr9:22636866-22636923	NONHSAT130440

Variant related genes	Relation type
ENSG00000234840	TF binding region

Extended variants
information (count: 3737 )
Associated
traits (count: 152 )

Variant overlapped rSNPs/rCNVs (count:3737 , 50 per page) page: 1 2 3 4 5 6 7 ... 75

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs57168082	chr9:22597800-22597801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs10124247	chr9:22597823-22597824	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs10124298	chr9:22597831-22597832	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs553673375	chr9:22597870-22597871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs191625726	chr9:22597959-22597960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs138894406	chr9:22598139-22598140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs543374742	chr9:22598140-22598141	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs75811710	chr9:22598158-22598159	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs79413356	chr9:22598159-22598160	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs575784534	chr9:22598191-22598192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs545096959	chr9:22598213-22598214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs564794763	chr9:22598247-22598248	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs182427565	chr9:22598283-22598284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs576900977	chr9:22598309-22598310	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs541109985	chr9:22598318-22598319	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs73650131	chr9:22598370-22598371	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs73452306	chr9:22598407-22598408	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs530456331	chr9:22598412-22598413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs142014652	chr9:22598436-22598437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs146368667	chr9:22598478-22598479	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs538819578	chr9:22598494-22598495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs111280974	chr9:22598496-22598497	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs80013280	chr9:22598497-22598498	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs139655087	chr9:22598541-22598542	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs542844637	chr9:22598585-22598586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs535098287	chr9:22598597-22598598	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs142009912	chr9:22598598-22598599	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs187016664	chr9:22598612-22598613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs560984413	chr9:22598636-22598637	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs150704407	chr9:22598666-22598667	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs10217416	chr9:22598741-22598742	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs373506447	chr9:22598745-22598746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs544845066	chr9:22598754-22598755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs565068857	chr9:22598762-22598763	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs572078968	chr9:22598797-22598798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs62573474	chr9:22598800-22598801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs560913899	chr9:22598891-22598892	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs10217763	chr9:22598914-22598915	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs73650132	chr9:22598917-22598918	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs10217764	chr9:22598995-22598996	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs191113322	chr9:22599009-22599010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs139977196	chr9:22599023-22599024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs73650133	chr9:22599027-22599028	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs373359668	chr9:22599048-22599049	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs73452310	chr9:22599074-22599075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs548229246	chr9:22599078-22599079	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs10811744	chr9:22599131-22599132	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs184509074	chr9:22599157-22599158	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs73650134	chr9:22599199-22599200	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs370396294	chr9:22599200-22599201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:152)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Glioblastoma multiforme	21569311	CNVD
Myelofibrosis	22110671	CNVD
Ewing''s sarcoma	22429812	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Lung cancer	21911935	CNVD
Primary central nervous system lymphoma	21088137	CNVD
head and neck squamous cell carcinoma	21798897	CNVD
Cancer	21253487	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Glioblastoma multiforme	21922591	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Urothelial cell carcinoma	18451213	CNVD
Glioma	17123091	CNVD
Mental retardation	17124404	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Leukemia	19602459	CNVD
Acute monocytic leukemia	16498392	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Leukemia	18688285	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Glioma	20126413	CNVD
Melanoma	17363583	CNVD
Glioblastoma multiforme	19115005	CNVD
Glioblastoma multiforme	21138945	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Cancer	20581869	CNVD
Oral cancer	22144094	CNVD
Barrett''s syndrome	19417022	CNVD
Breast cancer	17142309	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	17237825	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Glioblastoma multiforme	21525872	CNVD

Chromatin state (count:255 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:22593400-22599000	Weak transcription	HUES64 Cell Line	embryonic stem cell
2	chr9:22596000-22618000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
3	chr9:22596400-22601200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr9:22597400-22597800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr9:22597800-22600000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr9:22599000-22601000	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr9:22599800-22601000	Enhancers	HUES6 Cell Line	embryonic stem cell
8	chr9:22600000-22600800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr9:22600800-22601200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr9:22601000-22601400	Weak transcription	HUES64 Cell Line	embryonic stem cell
11	chr9:22601200-22601800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr9:22601800-22603400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr9:22603400-22603800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr9:22603800-22607600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr9:22607400-22607800	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr9:22607400-22608400	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr9:22607600-22608000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr9:22607800-22608400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr9:22607800-22608400	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr9:22608000-22610400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr9:22608400-22609600	Weak transcription	HUES64 Cell Line	embryonic stem cell
22	chr9:22608400-22610000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr9:22608400-22610400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
24	chr9:22610000-22610600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr9:22610400-22610600	Enhancers	HUES64 Cell Line	embryonic stem cell
26	chr9:22610400-22610800	Enhancers	iPS-20b Cell Line	embryonic stem cell
27	chr9:22610400-22611000	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr9:22610400-22612600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr9:22610600-22610800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr9:22615200-22615800	Active TSS	Fetal Heart	heart
31	chr9:22616600-22618000	Enhancers	Psoas Muscle	Psoas
32	chr9:22616600-22618000	Enhancers	Skeletal Muscle Female	skeletal muscle
33	chr9:22617000-22618000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr9:22617200-22617800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr9:22617400-22618000	Enhancers	Skeletal Muscle Male	skeletal muscle
36	chr9:22617800-22622600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr9:22618000-22622800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr9:22622200-22623400	Enhancers	Fetal Stomach	stomach
39	chr9:22622200-22623600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr9:22622600-22624400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr9:22622800-22623400	Enhancers	Ovary	ovary
42	chr9:22622800-22623600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr9:22622800-22624000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr9:22623000-22623400	Enhancers	H1 Cell Line	embryonic stem cell
45	chr9:22623000-22623400	Enhancers	HUES6 Cell Line	embryonic stem cell
46	chr9:22623000-22623600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr9:22623000-22623800	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr9:22623000-22624000	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr9:22623200-22623800	Enhancers	HUES48 Cell Line	embryonic stem cell
50	chr9:22623200-22623800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links